FindTrial
Sign In

Effect of hangeshashinto on diarrhea associated with chemotherapy

Effect of hangeshashinto on diarrhea associated with chemotherapy - Effect of hangeshashinto on diarrhea associated with chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049104
Enrollment
100
Registered
2022-10-07
Start date
2022-10-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasms

Interventions

None listed

Sponsors

Akita City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Randomized controlled trials that: Patients: Cancer patients receiving chemotherapy Interventions: Patients using hangeshashinto Comparison: Patients not using hangeshashinto Outcomes: diarrhea

Exclusion criteria

Exclusion criteria: Wrong study design(non-randomized controlled trial) No assessment of diarrhea

Design outcomes

Primary

MeasureTime frame
Common Terminology Criteria for Adverse Events: grade 3 and 4 diarrhea—

Secondary

MeasureTime frame
Common Terminology Criteria for Adverse Events: grade 0 and 2 diarrhea—

Countries

Japan

Contacts

Public ContactTakeru Takahashi

Akita City Hospital Department of Pharmacy

ra33xb86@gmail.com018-823-4171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026